When these substances or their derivatives are injected intramuscularly or into joint spaces, their relative properties may be greatly altered.We comply with the HONcode standard for trustworthy health information - Killed or inactivated vaccines may be administered. Kenalog®-40 Injection (triamcinolone acetonide injectable suspension, USP) is supplied in vials providing 40 mg triamcinolone acetonide per mL. Additional symptoms may include gradual neurological deterioration, seizures, intracranial hemorrhage, hematologic abnormalities, skin breakdown, hepatic and renal failure, hypotension, bradycardia and cardiovascular collapse. All registered trademarks, used in the content, are the property of their owners. in accordance with our privacy policies. Serious Neurologic Adverse Reactions with Epidural AdministrationAmphotericin B injection and potassium-depleting agentsAmoeba, Candida, Cryptococcus, Mycobacterium, Nocardia, Pneumocystis,Administration of live or live, attenuated vaccines is contraindicated in patients receiving immunosuppressive doses of corticosteroids. If chicken pox develops, treatment with antiviral agents should be considered.Epidural and intrathecal administration of this product is not recommended. 40 mg/mL, 1 mL. Caution should be exercised when corticosteroids are administered to a nursing woman.This product contains benzyl alcohol as a preservative. Corticosteroids should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Kenalog ®-40 Injection (triamcinolone acetonide injectable suspension, USP) is supplied in vials providing 40 mg triamcinolone acetonide per mL. Triamcinolone acetonide injectable Suspension, USP is supplied in vials providing 40 mg triamcinolone acetonide per mL. Studies indicate that following a single intramuscular dose of 60 mg to 100 mg of triamcinolone acetonide, adrenal suppression occurs within 24 to 48 hours and then gradually returns to normal, usually in 30 to 40 days. THIS FORMULATION IS NOT FOR INTRADERMAL INJECTION.Each mL of the sterile aqueous suspension provides 40 mg triamcinolone acetonide, USP, with 0.65% sodium chloride for isotonicity, 0.99% (w/v) benzyl alcohol as a preservative, 0.75% carboxymethylcellulose sodium, and 0.04% polysorbate 80 in an aqueous suspension. Premature and low-birth-weight infants, as well as patients receiving high dosages, may be more likely to develop toxicity. Practitioners administering this and other medications containing benzyl alcohol should consider the combined daily metabolic load of benzyl alcohol from all sources.The efficacy and safety of corticosteroids in the pediatric population are based on the well-established course of effect of corticosteroids which is similar in pediatric and adult populations. Kenalog-40 (Triamcinolone Acetonide) The NDC Code 0003-0293-20 is assigned to “Kenalog-40 ” (also known as: “Triamcinolone Acetonide”), a human prescription drug labeled by “E.R. Squibb & Sons, L.L.C. 40 mg/mL, 5 mL. However, the response to such vaccines cannot be predicted.Amphotericin B injection and potassium-depleting agents:Hepatic enzyme inducers (e.g., barbiturates, phenytoin, carbamazepine, rifampin):To report SUSPECTED ADVERSE REACTIONS, contact NorthStar Rx LLC at 1-800-206-7821 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND THE RESPONSE OF THE PATIENT.For the purpose of comparison, the following is the equivalent milligram dosage of the various glucocorticoids:These dose relationships apply only to oral or intravenous administration of these compounds. The NDC Code 0003-0293-20 is assigned to “Kenalog-40 ” (also known as: “Triamcinolone Acetonide”), a human prescription drug labeled by “E.R. If this complication occurs and the diagnosis of sepsis is confirmed, appropriate antimicrobial therapy should be instituted.Injection of a steroid into an infected site is to be avoided. If steroid therapy is continued for more than 6 weeks, intraocular pressure should be monitored.Patients should be warned not to discontinue the use of corticosteroids abruptly or without medical supervision, to advise any medical attendants that they are taking corticosteroids, and to seek medical advice at once should they develop fever or other signs of infection.Persons who are on corticosteroids should be warned to avoid exposure to chicken pox or measles. Epicondylitis may be treated by infiltrating the preparation into the area of greatest tenderness.Triamcinolone acetonide injectable Suspension, USP is supplied in vials providing 40 mg triamcinolone acetonide per mL.1 single-dose vial in 1 carton: NDC 16714-130-0125 single-dose vials in 1 carton: NDC 16714-130-255 mL multiple-dose vial (200 mg per 5 mL) in 1 carton: NDC 16714-140-0110 mL multiple-dose vial (400 mg per 10 mL) in 1 carton: NDC 16714-150-01Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Infection with any pathogen (viral, bacterial, fungal, protozoan, or helminthic) in any location of the body may be associated with the use of corticosteroids alone or in combination with other immunosuppressive agents.